Company / Free Cash Flow per Share
Emergent BioSolutions Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$3.01
FY2025
5-year range
-$4.94 / $3.01
FY2021-FY2025
Trend
+356.5%
vs FY2024
Sector context
#27 of 192
Health Care
What the data says
Free Cash Flow per Share changed +356% YoY in FY2025, a notable deviation from the 9-year average annual change of +176%.
Based on SEC 10-K filings.
3.01 in FY2025 with a 5-year CAGR of -17.0%. Top quartile in the Health Care sector.
Improved from $-4.94 to $3.01 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -17.0%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 192This company $3.01 Sector average -$19.84
▼
+115.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 356.5% year-over-year.
- Ranks #27 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.01 | +356.5% |
| FY2024 | $0.66 | +113.3% |
| FY2023 | -$4.94 | -69.1% |
| FY2022 | -$2.92 | -256.0% |
| FY2021 | $1.87 | -75.5% |
| FY2020 | $7.64 | +290.7% |
| FY2019 | $1.96 | +547.2% |
| FY2018 | -$0.44 | -111.6% |
| FY2017 | $3.78 | +789.3% |
| FY2016 | -$0.55 | -800.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026